HDAC2 and multiple sclerosis: In particular, we have shown that Theophylline promotes remyelination in the lysolecithin-induced mouse model of multiple sclerosis lesion, through activating and upregulating HDAC2 [14], warranting future clinical trials to test the efficiency of Theophylline in remyelinating lesions of multiple sclerosis patients.